SCHEMBL11213671

SCHEMBL11213671

O=Nc1ccc(O)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.53
▸ PTGS2 P35354 1/20 0.53
▸ HSD17B10 Q99714 4/20 0.50
▸ TSHR P16473 2/20 0.50
▸ CA2 P00918 2/20 0.46
▸ CA1 P00915 1/20 0.46
▸ ESR2 Q92731 2/20 0.42
▸ BRD4 O60885 1/20 0.41
▸ HPGD P15428 1/20 0.39
▸ ESR1 P03372 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ HTR3E A5X5Y0 1/20 0.38
▸ HTR3B O95264 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28202777 0.98 PTGS1 (0.51) PTGS1PTGS2HSD17B10TSHRCA2
SCHEMBL21125070 0.81 PTGS1 (0.67) PTGS1PTGS2HSD17B10TSHRCA2
SCHEMBL12116179 0.78 MAPK1 (0.58) HSD17B10TSHRCYP3A4TDP1HTR3E
SCHEMBL30396176 0.78 MAPK1 (0.58) HSD17B10TSHRCYP3A4TDP1HTR3E
SCHEMBL3316934 0.78 PTGS2 (0.48) PTGS1PTGS2HSD17B10CA2CA1
SCHEMBL12228262 0.74 MAPT (0.40) PTGS1PTGS2HSD17B10TSHRCA2
SCHEMBL28253003 0.74 MAPK1 (0.39) PTGS1PTGS2HSD17B10TSHRHPGD
SCHEMBL25453428 0.74 PTGS1 (0.54) PTGS1PTGS2HSD17B10TSHRCA2
SCHEMBL2448393 0.74 HSD17B10 (0.46) PTGS1PTGS2HSD17B10TSHRCA2
SCHEMBL798232 0.73 HSD17B10 (0.41) HSD17B10TSHRESR2ESR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111051468-B Homogeneous anaerobically stable quantum dot concentrates 昭荣化学工业株式会社 2024-06-04 — — CN disclosed
US-11584646-B2 Homogeneous anaerobically stable quantum dot concentrates NANOSYS, INC. (US) 2023-02-21 — — US disclosed
US-20210130170-A1 HOMOGENEOUS ANAEROBICALLY STABLE QUANTUM DOT CONCENTRATES NANOSYS, INC. (US) 2021-05-06 — — US disclosed
US-10919770-B2 Homogeneous anaerobically stable quantum dot concentrates NANOSYS, INC. (US) 2021-02-16 — — US disclosed
CN-111051468-A Homogeneous anaerobically stable quantum dot concentrates 纳米系统公司 2020-04-21 — — CN disclosed
WO-2018237236-A1 HOMOGENEOUS ANAEROBICALLY STABLE QUANTUM DOT CONCENTRATES SMITH AUSTIN (US) 2018-12-27 — — WO disclosed
US-20180370800-A1 HOMOGENEOUS ANAEROBICALLY STABLE QUANTUM DOT CONCENTRATES NANOSYS, INC. (US) 2018-12-27 — — US disclosed
EP-0020065-B1 A METHOD FOR INHIBITING THE POLYMERIZATION OF ACRYLIC MONOMERS IN AQUEOUS LIQUIDS CONTAINING THEM ROHM AND HAAS COMPANY (US) 1983-02-23 — — EP disclosed
EP-0020065-A1 A method for inhibiting the polymerization of acrylic monomers in aqueous liquids containing them ROHM AND HAAS COMPANY (US) 1980-12-10 — — EP disclosed
Send feedback